Removal of an intracardiac lost port-A catheter utilizing a simple low-cost method
2014; Elsevier BV; Volume: 176; Issue: 3 Linguagem: Inglês
10.1016/j.ijcard.2014.07.156
ISSN1874-1754
AutoresPlacido Romeo, Giuseppe Mario Calvagna, Marco Giunta, Felice Vito Vitale, Salvatore Patanè,
Tópico(s)Central Venous Catheters and Hemodialysis
ResumoThe intravenous port-A catheters are widely used for long-term central venous access [ 1 Choksy P. Zaidi S.S. Kapoor D. Removal of intracardiac fractured port-A catheter utilizing an existing forearm peripheral intravenous access site in the cath lab. J Invasive Cardiol. Feb 2014; 26: 75-76 PubMed Google Scholar , 2 Lin M.C. Chang T.K. Fu Y.C. Jan S.L. A magic port-A-cath. JACC Cardiovasc Interv. Mar 2013; 6: e17-e18 Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar , 3 Mousa A.Y. Gill G. Aburahma A.F. New trick for removal of intravascular retained foreign body: a case report and review of literature. Vasc Endovascular Surg. Jan 2014; 48: 55-57 Crossref PubMed Scopus (2) Google Scholar ] in cancer patients [ 1 Choksy P. Zaidi S.S. Kapoor D. Removal of intracardiac fractured port-A catheter utilizing an existing forearm peripheral intravenous access site in the cath lab. J Invasive Cardiol. Feb 2014; 26: 75-76 PubMed Google Scholar , 4 Scott J.M. Jones L.W. Hornsby W.E. et al. Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training. Int J Cardiol. Feb 1 2014; 171: e50-e51 Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar , 5 Claridge S. Chakrabarti A. Greaves K. Boos C.J. Successful use of trastuzumab following cardiac resynchronisation therapy. Int J Cardiol. Jun 20 2013; 166: e33-e34 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 6 Lotrionte M. Palazzoni G. Abbate A. et al. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue doppler imaging Evaluation) randomized pilot study. Int J Cardiol. Aug 10 2013; 167: 1055-1057 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 7 Kaya M.G. Ozkan M. Gunebakmaz O. et al. Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. Int J Cardiol. Sep 1 2013; 167: 2306-2310 Abstract Full Text Full Text PDF PubMed Scopus (238) Google Scholar , 8 Wang K.L. Liu C.J. Chao T.F. et al. Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis. Int J Cardiol. Sep 1 2013; 167: 2162-2166 Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar , 9 Hu Y.F. Liu C.J. Chang P.M. et al. Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol. May 10 2013; 165: 355-357 Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar , 10 Budaj-Fidecka A. Kurzyna M. Fijałkowska A. et al. ZATPOL Registry Investigators. In-hospital major bleeding predicts mortality in patients with pulmonary embolism: an analysis of ZATPOL registry data. Int J Cardiol. Oct 9 2013; 168: 3543-3549 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 11 Pugliatti P. Donato R. Di Bella G. Carerj S. Patanè S. Contrast-enhancing right atrial thrombus in cancer patient. Int J Cardiol. May 15 2014; 173: e35-e37 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 12 Grover S. Leong D.P. Chakrabarty A. et al. Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: a prospective study using novel cardiac imaging and biochemical markers. Int J Cardiol. Oct 15 2013; 168: 5465-5467 Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar , 13 Jurczak W. Szmit S. Sobociński M. et al. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol. Oct 15 2013; 168: 5212-5217 Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar , 14 Cardioncology Lestuzzi C. Oncocardiology. Are we barking up the wrong tree?. Int J Cardiol. Jul 31 2013; 167: 307-309 Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar , 15 Pugliatti P. Donato R. Zito C. Carerj S. Patanè S. Cardio inhibitory vasovagal syncope in a cancer patient. Int J Cardiol. Jun 15 2014;174(2):e64-5; PubMed Google Scholar , 16 Pugliatti P. De Gregorio C. Patanè S. The chance finding of echocardiographic complications of infective endocarditis. Int J Cardiol. Nov 29 2012; 161: e50-e51 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 17 Patanè S. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1085-1088 Google Scholar , 18 Elkina Y. Palus S. Tschirner A. et al. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia. Int J Cardiol. Dec 10 2013; 170: 160-166 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 19 Springer J. Tschirner A. Hartman K. von Haehling S. Anker S.D. Doehner W. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy. Int J Cardiol. Oct 9 2013; 168: 3527-3531 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 20 Palus S. von Haehling S. Flach V.C. et al. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. Int J Cardiol. Oct 9 2013; 168: 3412-3418 Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar , 21 Avbelj V. Trobec R. A closer look at electrocardiographic P waves before and during spontaneous cardioinhibitory syncope. Int J Cardiol. Jul 1 2013; 166: e59-e61 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 22 Jang W.J. Yim H.R. Lee S.H. Park S.J. Kim J.S. On Y.K. Prognosis after tilt training in patients with recurrent vasovagal syncope. Int J Cardiol. Oct 9 2013; 168: 4264-4265 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 23 Loh K.P. Ogunneye O. Malignant cardioinhibitory vasovagal syncope — an uncommon cardiovascular complication of Roux-en-Y gastric bypass surgery: the fainting syndrome!. Int J Cardiol. Apr 15 2013; 164: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 24 Patanè S. Marte F. Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system. Eur Heart J. May 2009; 30: 1169-1170 Crossref PubMed Scopus (37) Google Scholar , 25 Arcopinto M. Cella C.A. Wesolowski R. et al. Primary prevention of cancer-related thrombosis: Special focus on ambulatory patients. Int J Cardiol. May 15 2014; 173: 583-584 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 26 Patanè S. Breast cancer treatment cardioprotective strategies: the King is naked. J Am Heart Assoc. 2014; (Published July 22,2014 http://www.jaha.ahajournals.org/content/3/2/e000665/reply) Google Scholar , 27 Cardinale D. A new frontier: cardio-oncology. Cardiologia Sep. 1996; 41: 887-891 PubMed Google Scholar , 28 Patanè S. Marte F. Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going?. Int J Cardiol. Jan 7 2011; 146: e20-e22 Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar , 29 Patanè S. Marte F. Prostate-specific antigen and acute myocardial infarction: a possible new intriguing scenario. Int J Cardiol. May 29 2009; 134: e147-e149 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 30 Patanè S. Prostate-specific antigen kallikrein and the heart. World J Cardiol. Dec 31 2009; 1: 23-25 Crossref PubMed Google Scholar , 31 Scarano M. Pezzuoli F. Torrisi G. Calvagna G.M. Patanè S. Cardiovascular implantable electronic device infective endocarditis. Int J Cardiol. May 15 2014; 173: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 32 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?. J Cardiovasc Transl Res. Apr 2014; 7: 369-371 Crossref PubMed Scopus (41) Google Scholar , 33 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing Gastrointestinal Endoscopy?. J Cardiovasc Transl Res. Apr 2014; 7: 372-374 Crossref PubMed Scopus (39) Google Scholar , 34 Patanè S. A dark side of the cardio-oncology: the bacterial endocarditis prophylaxis. Int J Cardiol. Jun 14 2012; 157: 448-449 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 35 Patanè S. Cardiotoxicity: cisplatin and long term cancer survivors. Int J Cardiol. Jul 15 2014; 175: 201-202 Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar , 36 Patanè S. A challenge in cardiology: the oncosurgery. Int J Cardiol. Jun 15 2014; 174: 411-412 Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar , 37 Patanè S. Insights into cardio-oncology: adrenergic receptor signaling and pathways in breast cancer. Curr Med Res Opin. Jun 2014; 26 (http://informahealthcare.com): 1-2 Crossref Scopus (1) Google Scholar , 38 Patanè S. Marte F. Sturiale M. Dattilo G. ST-segment elevation and diminution of prostate-specific antigen in a patient with coronary spasm and without significant coronary stenoses. Int J Cardiol. Apr 14 2011; 148: e31-e33 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 39 Ozkanlar Y. Aktas M.S. Turkeli M. et al. Effects of ramipril and darbepoetin on electromechanical activity of the heart in doxorubicin-induced cardiotoxicity. Int J Cardiol. May 15 2014; 173: 519-521 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar , 40 Patanè S. Cardiotoxicity: Anthracyclines and long term cancer survivors. Int J Cardiol. 2014; 176: 1329-1331 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar , 41 Patanè S. Heart failure and breast cancer: emerging controversies regarding some cardioprotective strategies. J Card Fail. Jun 2014; 20: 456-457 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 42 Patanè S. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1309-1311 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar , 43 Patanè S. ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1301-1303 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar , 44 Conti E. Romiti A. Musumeci M.B. et al. Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors. Int J Cardiol. Sep 10 2013; 167: 2421-2429 Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar , 45 Rateesh S. Luis S.A. Luis C.R. Hughes B. Nicolae M. Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge?. Int J Cardiol. Mar 15 2014; 172: e331-e333 Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar , 46 Kurisu S. Iwasaki T. Ishibashi K. Mitsuba N. Dohi Y. Kihara Y. Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients. Int J Cardiol. Sep 1 2013; 167: 2335-2337 Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar ]. Spontaneous fracture and migration of implanted port catheters is a known complication and necessitates immediate removal [ 1 Choksy P. Zaidi S.S. Kapoor D. Removal of intracardiac fractured port-A catheter utilizing an existing forearm peripheral intravenous access site in the cath lab. J Invasive Cardiol. Feb 2014; 26: 75-76 PubMed Google Scholar , 2 Lin M.C. Chang T.K. Fu Y.C. Jan S.L. A magic port-A-cath. JACC Cardiovasc Interv. Mar 2013; 6: e17-e18 Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar , 3 Mousa A.Y. Gill G. Aburahma A.F. New trick for removal of intravascular retained foreign body: a case report and review of literature. Vasc Endovascular Surg. Jan 2014; 48: 55-57 Crossref PubMed Scopus (2) Google Scholar , 4 Scott J.M. Jones L.W. Hornsby W.E. et al. Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training. Int J Cardiol. Feb 1 2014; 171: e50-e51 Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar , 5 Claridge S. Chakrabarti A. Greaves K. Boos C.J. Successful use of trastuzumab following cardiac resynchronisation therapy. Int J Cardiol. Jun 20 2013; 166: e33-e34 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 6 Lotrionte M. Palazzoni G. Abbate A. et al. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue doppler imaging Evaluation) randomized pilot study. Int J Cardiol. Aug 10 2013; 167: 1055-1057 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 7 Kaya M.G. Ozkan M. Gunebakmaz O. et al. Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. Int J Cardiol. Sep 1 2013; 167: 2306-2310 Abstract Full Text Full Text PDF PubMed Scopus (238) Google Scholar , 8 Wang K.L. Liu C.J. Chao T.F. et al. Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis. Int J Cardiol. Sep 1 2013; 167: 2162-2166 Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar , 9 Hu Y.F. Liu C.J. Chang P.M. et al. Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol. May 10 2013; 165: 355-357 Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar , 10 Budaj-Fidecka A. Kurzyna M. Fijałkowska A. et al. ZATPOL Registry Investigators. In-hospital major bleeding predicts mortality in patients with pulmonary embolism: an analysis of ZATPOL registry data. Int J Cardiol. Oct 9 2013; 168: 3543-3549 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 11 Pugliatti P. Donato R. Di Bella G. Carerj S. Patanè S. Contrast-enhancing right atrial thrombus in cancer patient. Int J Cardiol. May 15 2014; 173: e35-e37 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 12 Grover S. Leong D.P. Chakrabarty A. et al. Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: a prospective study using novel cardiac imaging and biochemical markers. Int J Cardiol. Oct 15 2013; 168: 5465-5467 Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar , 13 Jurczak W. Szmit S. Sobociński M. et al. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol. Oct 15 2013; 168: 5212-5217 Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar , 14 Cardioncology Lestuzzi C. Oncocardiology. Are we barking up the wrong tree?. Int J Cardiol. Jul 31 2013; 167: 307-309 Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar , 15 Pugliatti P. Donato R. Zito C. Carerj S. Patanè S. Cardio inhibitory vasovagal syncope in a cancer patient. Int J Cardiol. Jun 15 2014;174(2):e64-5; PubMed Google Scholar , 16 Pugliatti P. De Gregorio C. Patanè S. The chance finding of echocardiographic complications of infective endocarditis. Int J Cardiol. Nov 29 2012; 161: e50-e51 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 17 Patanè S. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1085-1088 Google Scholar , 18 Elkina Y. Palus S. Tschirner A. et al. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia. Int J Cardiol. Dec 10 2013; 170: 160-166 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 19 Springer J. Tschirner A. Hartman K. von Haehling S. Anker S.D. Doehner W. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy. Int J Cardiol. Oct 9 2013; 168: 3527-3531 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 20 Palus S. von Haehling S. Flach V.C. et al. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. Int J Cardiol. Oct 9 2013; 168: 3412-3418 Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar , 21 Avbelj V. Trobec R. A closer look at electrocardiographic P waves before and during spontaneous cardioinhibitory syncope. Int J Cardiol. Jul 1 2013; 166: e59-e61 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 22 Jang W.J. Yim H.R. Lee S.H. Park S.J. Kim J.S. On Y.K. Prognosis after tilt training in patients with recurrent vasovagal syncope. Int J Cardiol. Oct 9 2013; 168: 4264-4265 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 23 Loh K.P. Ogunneye O. Malignant cardioinhibitory vasovagal syncope — an uncommon cardiovascular complication of Roux-en-Y gastric bypass surgery: the fainting syndrome!. Int J Cardiol. Apr 15 2013; 164: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 24 Patanè S. Marte F. Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system. Eur Heart J. May 2009; 30: 1169-1170 Crossref PubMed Scopus (37) Google Scholar , 25 Arcopinto M. Cella C.A. Wesolowski R. et al. Primary prevention of cancer-related thrombosis: Special focus on ambulatory patients. Int J Cardiol. May 15 2014; 173: 583-584 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 26 Patanè S. Breast cancer treatment cardioprotective strategies: the King is naked. J Am Heart Assoc. 2014; (Published July 22,2014 http://www.jaha.ahajournals.org/content/3/2/e000665/reply) Google Scholar , 27 Cardinale D. A new frontier: cardio-oncology. Cardiologia Sep. 1996; 41: 887-891 PubMed Google Scholar , 28 Patanè S. Marte F. Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going?. Int J Cardiol. Jan 7 2011; 146: e20-e22 Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar , 29 Patanè S. Marte F. Prostate-specific antigen and acute myocardial infarction: a possible new intriguing scenario. Int J Cardiol. May 29 2009; 134: e147-e149 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 30 Patanè S. Prostate-specific antigen kallikrein and the heart. World J Cardiol. Dec 31 2009; 1: 23-25 Crossref PubMed Google Scholar , 31 Scarano M. Pezzuoli F. Torrisi G. Calvagna G.M. Patanè S. Cardiovascular implantable electronic device infective endocarditis. Int J Cardiol. May 15 2014; 173: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 32 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?. J Cardiovasc Transl Res. Apr 2014; 7: 369-371 Crossref PubMed Scopus (41) Google Scholar , 33 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing Gastrointestinal Endoscopy?. J Cardiovasc Transl Res. Apr 2014; 7: 372-374 Crossref PubMed Scopus (39) Google Scholar , 34 Patanè S. A dark side of the cardio-oncology: the bacterial endocarditis prophylaxis. Int J Cardiol. Jun 14 2012; 157: 448-449 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 35 Patanè S. Cardiotoxicity: cisplatin and long term cancer survivors. Int J Cardiol. Jul 15 2014; 175: 201-202 Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar , 36 Patanè S. A challenge in cardiology: the oncosurgery. Int J Cardiol. Jun 15 2014; 174: 411-412 Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar , 37 Patanè S. Insights into cardio-oncology: adrenergic receptor signaling and pathways in breast cancer. Curr Med Res Opin. Jun 2014; 26 (http://informahealthcare.com): 1-2 Crossref Scopus (1) Google Scholar , 38 Patanè S. Marte F. Sturiale M. Dattilo G. ST-segment elevation and diminution of prostate-specific antigen in a patient with coronary spasm and without significant coronary stenoses. Int J Cardiol. Apr 14 2011; 148: e31-e33 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 39 Ozkanlar Y. Aktas M.S. Turkeli M. et al. Effects of ramipril and darbepoetin on electromechanical activity of the heart in doxorubicin-induced cardiotoxicity. Int J Cardiol. May 15 2014; 173: 519-521 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar , 40 Patanè S. Cardiotoxicity: Anthracyclines and long term cancer survivors. Int J Cardiol. 2014; 176: 1329-1331 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar , 41 Patanè S. Heart failure and breast cancer: emerging controversies regarding some cardioprotective strategies. J Card Fail. Jun 2014; 20: 456-457 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 42 Patanè S. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1309-1311 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar , 43 Patanè S. ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014 Aug 2; 176: 1301-1303 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar , 44 Conti E. Romiti A. Musumeci M.B. et al. Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors. Int J Cardiol. Sep 10 2013; 167: 2421-2429 Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar , 45 Rateesh S. Luis S.A. Luis C.R. Hughes B. Nicolae M. Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge?. Int J Cardiol. Mar 15 2014; 172: e331-e333 Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar , 46 Kurisu S. Iwasaki T. Ishibashi K. Mitsuba N. Dohi Y. Kihara Y. Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients. Int J Cardiol. Sep 1 2013; 167: 2335-2337 Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar ]. Transvenous extraction technique of foreign intravascular bodies and lead catheters is commonly performed [ 46 Kurisu S. Iwasaki T. Ishibashi K. Mitsuba N. Dohi Y. Kihara Y. Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients. Int J Cardiol. Sep 1 2013; 167: 2335-2337 Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar , 47 Calvagna G.M. Patanè S. Severe staphylococcal sepsis in patient with permanent pacemaker. Int J Cardiol. Apr 1 2014; 172: e498-e501 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 48 Ward C. Henderson S. Metcalfe N.H. A short history on pacemakers. Int J Cardiol. Nov 15 2013; 169: 244-248 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 49 Ahmed S. Ungprasert P. Srivali N. Ratanapo S. Cheungpasitporn W. Chongnarungsin D. Lead perforation: an uncommon cause of chest pain in a patient with pacemaker. Int J Cardiol. Sep 1 2013; 167: e113-e114 Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar , 50 Calvagna G.M. Ceresa F. Patanè S. Subcutaneous implantable cardioverter–defibrillator in a young woman. Int J Cardiol. Aug 1 2014; 175: e30-e32 Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar , 51 Calvagna G.M. Recall, malfunzionamenti e infezioni in portatori di PM/ICD. Possono condizionare le scelte clinico-interventistiche e la qualità della vita?. GIAC. 2010; 13: 217-222 Google Scholar , 52 Calvagna G.M. Progressivo malfunzionamento di elettrocatetere da stimolazione cardiaca permanente secondario a processo infettivo asintomatico. GIAC. 2012; 15: 51-54 Google Scholar , 53 Calvagna G.M. Curatolo S. La Greca S. Evola R. Sepsi Stafilococciche in pazienti portatori di PM e\o ICD: Dal trattamento antibiotico all'intervento di Rimozione Transvenosa Manuale. G Ital Aritmol Cardiostim. Marzo 2010; 13: 1 Google Scholar , 54 Calvagna G.M. Mangano A. Evola R. Infezioni su estremita' distali degli elettrocateteri da stimolazione cardiaca permanente rimossi mediante tecnica transvenosa manuale:casistica dal 2002 al 2007 presso centro unico dedicato. G Ital Aritmol Cardiostim. 2008; 4: 65-68 Google Scholar , 55 Woodhouse J.B. Uberoi R. Techniques for intravascular foreign body retrieval. Cardiovasc Intervent Radiol Aug. 2013; 36: 888-897 Crossref PubMed Scopus (51) Google Scholar , 56 Kawata H. Patel J. McGarry T. et al. Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation. Int J Cardiol. Apr 1 2014; 172: e522-e524 Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar , 57 Calvagna G.M. Evola R. Complicanze non infettive o malfunzionamenti in pazienti portatori di PM e/o ICD: importanza della rimozione transvenosa. G Ital Aritmol Cardiostim. 2009; 12: 69-78 Google Scholar , 58 Calvagna G.M. Patanè S. Romeo P. Ceresa F. Sansone F. Patanè F. Embolization and retrieval of an anchoring sleeve during transvenous lead extraction. Int J Cardiol. May 15 2014; 173: e42-e44 Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar , 59 Calvagna G.M. Foti R. Lisi M. Evola R. Rimozione transvenosa manuale di elettrocateteri da Pacemaker e\o ICD malfunzionanti o infetti mediante tecnica transvenosa manuale: Esperienza di unico centro regionale dedicato (anni 2002–2007). G Ital Aritmol Cardiostim. 2007; 4: 30-35 Google Scholar , 60 Calvagna G.M. Evola R. Scardace G. Valsecchi S. Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace. Nov 2009; 11: 1505-1509 Crossref PubMed Scopus (42) Google Scholar , 61 Calvagna G.M. Evola R. Scardace G. Valsecchi S. Successful removal of a jugular implantable defibrillator lead with mechanical single-sheath technique. Pacing Clin Electrophysiol. Sep 2012; 35: e258-e260 Crossref PubMed Scopus (21) Google Scholar , 62 Calvagna G.M. Evola R. Valsecchi S. A complication of pacemaker lead extraction: pulmonary embolization of an electrode fragment. Europace. 2010; 12: 613 Crossref PubMed Scopus (23) Google Scholar , 63 Calvagna G.M. Romeo P. Ceresa F. Valsecchi S. Transvenous retrieval of foreign objects lost during cardiac device implantation or revision: a 10-year experience. Pacing Clin Electrophysiol. Jul 2013; 36: 892-897 Crossref PubMed Scopus (31) Google Scholar , 64 Calvagna G.M. Torrisi G. Giuffrida C. Patanè S. Pacemaker, implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life. Int J Cardiol. Jun 15 2014; 174: 378-380 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 65 Ceresa F. Sansone F. Patanè S. Calvagna G.M. Patanè F. Superior vena cava obstruction as late complication of biventricular pacemaker implantation: Surgical replacement of the malfunctioning previous leads. Int J Cardiol. 2014; 176: e83-e85 Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar , 66 Calvagna G.M. Patanè S. Transvenous pacemaker lead extraction in infective endocarditis. Int J Cardiol. 2014 Jul 12; 176: 1312-1314 Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar , 67 Rodriguez Y. Garisto J. Carrillo R.G. Management of cardiac device-related infections: a review of protocol-driven care. Int J Cardiol. Jun 5 2013; 166 ([Review]): 55-60 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 68 Cho H. Kim M. Uhm J.S. Pak H.N. Lee M.H. Joung B. Transvenous pacemaker lead removal in pacemaker lead endocarditis with large vegetations: a report of two cases. Korean Circ J. Mar 2014; 44: 118-121 Crossref PubMed Scopus (4) Google Scholar , 69 Singh N. Langer V. Chadha D.S. et al. Percutaneous removal of transvenous pacemaker leads using an extraction device. Med J Armed Forces India. Jul 2013; 69: 291-293 Abstract Full Text Full Text PDF Scopus (3) Google Scholar , 70 Bongiorni M.G. Soldati E. Zucchelli G. et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008; 29: 2886-2893 Crossref PubMed Scopus (205) Google Scholar , 71 Sohal M. Williams S.E. Arujuna A. et al. The current practice and perception of cardiac implantable electronic device transvenous lead extraction in the UK. Europace. Jun 2013; 15: 865-870 Crossref PubMed Scopus (17) Google Scholar ]. We describe the removal of an intracardiac lost port-A catheter utilizing a simple method with a material normally available in the laboratories of interventional radiology. In May 2010 we observed a patient with a malfunctioning left subclavian port-A catheter. Chest X-ray examination revealed the presence of spontaneous fracture and migration of implanted lead in the right atrium, with apexes positioned inside the right ventricular cavity. We proceeded to remove it because of the arrhythmias that were determined and of its potential infectious risk. The technical difficulty of the case was due to the fact that the systems to handle type goose-necks are easily usable when one of the heads of the catheters is in an accessible position and catchable with the handle. The intravascular placement of both catheter heads makes it more difficult to retrieve the system as well as it triggered ventricular arrhythmias that were not tolerated by the patient. In such situations and in the unavailability of retrieval sophisticated systems (Allison fragment grasper and vascular retrieval forceps), we tried to mobilize the port-A-cath by bending it with a pigtail catheter (Fig. 1 Panel A) which have a femoral vein access to attempt to bring one apex. In the case in question this attempt was unsuccessful because of the higher resistance offered by the catheter to the traction. To avoid repeating the procedure under more and more ‘adequate availability’ of materials we tried a combined approach with double femoral venous access. From the first venous access a modified pigtail catheter without a tip (umbrella handle like) was inserted, and by the second venous access a catheter snare (Fig. 1 (Panel B)) was inserted. Fig. 1 (Panel C) shows a chest-radiography with the dislodged port-A-cath. The umbrella handle like catheter blocked the lost catheter while the snare captured the tip of the modified pigtail then pulled both catheters at the same time. This procedure allowed finally the release of one tip of the lost catheter and then held it in the vena cava with the umbrella handle like catheter, to recover it with the snare, and take it out through one of the two used venous access sites. Fig. 2 (Panels A, B, and C) shows removal phases. The procedure has been successfully completed without complications. This simple low cost method may be useful in selected situations without the use of expensive and not always easily available specialized material. Fig. 2(Panels A, B, and C): removal phases. View Large Image Figure Viewer Download Hi-res image
Referência(s)